RIPK1 and neoplasm: RIPK1 inhibitor necrostatin-1 or endothelial-cell-specific RIPK3 deletion inhibited tumor cell-induced endothelial necroptosis, tumor cell extravasation, and metastasis in mice (Strilic et al., 2016).